13F HOLDINGS REPORT
BIOS Capital Management, LP
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001813845-26-000002
Total Value
$82.6M
Positions
9
Other Managers
1
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INC | ACTU | 8,594,141 | $52.6M | 63.66% |
| 2 | ACTUATE THERAPEUTICS INC | ACTU | 1,455,855 | $8.9M | 10.78% |
| 3 | COGNITION THERAPEUTICS INC | CGTX | 5,499,905 | $7.4M | 8.99% |
| 4 | OPUS GENETICS INC | IRD | 3,683,429 | $7.4M | 8.96% |
| 5 | LANTERN PHARMA INC | LTRN | 1,009,507 | $3.1M | 3.70% |
| 6 | REIN THERAPEUTICS INC | RNTX | 1,498,751 | $1.7M | 2.10% |
| 7 | COGNITION THERAPEUTICS INC | CGTX | 500,095 | $675,129 | 0.82% |
| 8 | IN8BIO INC | INAB | 253,417 | $592,996 | 0.72% |
| 9 | REIN THERAPEUTICS INC | RNTX | 192,000 | $222,720 | 0.27% |